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1. Introduction
Demyelinating encephalitis is a type of encephalitis in which the insulating myelin sheath sur‐
rounding nerve fibers is damaged. Most types of demyelinating encephalitis are known to be
caused by viral infection, and therefore the nature of viral persistence in the central nervous sys‐
tem (CNS) has become crucial to understanding the pathogenesis of associated diseases. Suba‐
cute sclerosing panencephalitis (SSPE) is a progressive fatal demyelinating disease caused by
infection with high levels of neuronal measles virus (MV) in the CNS. Thus, MV infection pro‐
vides one of the main paradigms of persistent viral infection that causes encephalitis. Many re‐
views have been published explaining how MV establishes a persistent infection in the CNS [1,
2, 3]. A number of studies on SSPE using cDNA cloning and sequencing techniques have re‐
vealed that MV genomes are present in samples obtained from SSPE patients. This demon‐
strates the presence of mutations that may lead to MV persistence in the CNS. However, no
study has been able to explain how persistent MV is reactivated and results in subsequent
pathogenesis of the CNS. In this review, we describe a brief overview of MV and SSPE. We will
attempt to focus on host cell modifications related to MV persistence, and on reactivation mech‐
anisms of MV during persistent infections. We will then discuss the pathogenesis of persistent
MV infections in patients to highlight molecular events that lead to the manifestation of SSPE
symptoms. These key advances in the understanding of MV persistence will provide novel in‐
sights into the elucidation of SSPE pathogenesis.
2. Measles and the CNS sequelae
Measles. Measles is a highly contagious respiratory disease caused by MV. More than 10
million people worldwide are affected by MV each year, resulting in several hundred thou‐
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sand deaths [4]. Clinical symptoms of infection are fever, cough, conjunctivitis, rash, and
Koplik spots. Immunosuppression for many weeks after apparent recovery is also a charac‐
teristic of MV infection. CNS involvement in measles is a common feature, although most
patients do not present with clinical evidence of encephalitis. However, transient electroen‐
cephalography abnormalities are observed in approximately 50% of patients [5]. Measles
can induce encephalitis in at least four different paradigms: primary measles encephalitis
(PME); acute post-infectious measles encephalomyelitis (APME); measles inclusion-body en‐
cephalitis (MIBE) and SSPE. PME and MIBE are caused by an active or ongoing MV infec‐
tion, but SSPE and APME are not. APME, which occurs in approximately 0.1% of MV cases
(with a lethality of approximately 20%), develops shortly after infection, but active virus is
not observed in the CNS. In APME and SSPE, neuropathological demyelination has been ob‐
served to develop.
SSPE. SSPE is a progressive fatal neurological disease that causes widespread demyelina‐
tion of the CNS and infection of neurons. This is followed by infection of oligodendrocytes,
astrocytes and endothelial cells [6]. It takes approximately 6–8 years after an acute MV infec‐
tion for the first symptoms of SSPE to appear [7, 8]. In the early stages, affected children
present with poor school performance. Motor regression is eventually seen in 100% of affect‐
ed individuals, and then the disease progresses to a vegetative state [9]. Serum and cerebro‐
spinal fluid (CSF) contain high, or very high, titers of antibodies against MV [10, 11].
Intranuclear and/or intracytoplasmic inclusion bodies are often present [12, 13]. Infiltrating
mononuclear cells are first apparent in the meninges, and perivascular cuffs and infiltrates
can become extensive. Some infected neurons and oligodendrocytes contain fibrillary tan‐
gles similar to those seen in other neurodegenerative diseases [14, 15].
MV. MV is a negative-sense, single-stranded RNA virus that belongs to the genus Morbillivi‐
rus, family Paramyxoviridae. The virus is composed of six structural proteins: nucleoprotein
(N), phosphoprotein (P), matrix protein (M), fusion protein (F), hemagglutinin (H), and
large protein (L). Among these structural proteins, the N, P, and L proteins are essential for
viral replication and transcription. MV genomic RNA is packaged into ribonucleoprotein
(RNP) complexes, consisting of the N protein and a viral RNA-dependent RNA polymerase
(RdRp). The RdRp is composed of the P and L proteins, both of which are responsible for
replication and transcription of the MV genome. In addition to these structural proteins, the
P gene of MV encodes accessory proteins, C and V.
MV persistence. MV produces not only an acute lytic infection, but also an occasional per‐
sistent infection. A growing body of evidence supports the persistence of MV in the infected
host. As an example, a boy who had been treated for granulomatous disease using stem cell
therapy died owing to MV complications [16]. Because neither the patient nor the stem cell
donor had recently been exposed to MV or been vaccinated, it is most likely that MV persist‐
ed in either the donor or the patient and was reactivated. It is possible that a MV infection
can persist throughout a patient’s lifetime without triggering overt disease [17]. It is also
possible that reactivation of a persistent MV infection can sometimes cause SSPE long after
the acute infection [18].
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SSPE virus strains. The sequences of viral genomes from SSPE cases are typically not re‐
lated  to  current  circulating  wild-type  viruses,  but  instead  to  those  in  circulation  when
patients developed an acute MV infection. This is confirmation that SSPE is caused by a
persistent MV infection [19, 20]. Genetic analyses have also revealed that persistent MVs
derived from SSPE cases (SSPE virus strains,  SSPEVs) contain numerous mutations.  The
existence of characteristic mutations common to SSPEVs has been suggested [21, 22]. The
M gene of SSPEVs appears to be particularly vulnerable to mutation, and its expression
is  restricted.  In  many SSPEVs,  an A-to-G hypermutation occurs  in  the  genome and de‐
stroys  the  M  protein-coding  frames.  Although  hypermutation  of  the  M  gene  results  in
the  defective  expression of  the  M protein,  replacement  of  the  M gene did not  confer  a
neurovirulent  phenotype  in  hamsters  [23].  Hypermutations  in  the  M  gene  likely  slow
down the migration of the virus and thereby prolong infection. A mutated M protein in‐
teracts at low affinity, or not at all, with RNP complexes and is associated with the accu‐
mulation  of  nucleocapsids  inside  infected  cells  [24].  Other  changes  in  SSPEV structural
proteins have been found in the F and H proteins. The F proteins of some SSPEVs have
been  demonstrated  to  contribute  to  neurovirulence  in  animals  by  showing  hyperfusion
activity  [23,  25].  The  H  protein  also  contributed  to  neurovirulence  to  some  extent  [23,
25], although it is not required for trans-synaptic transmission [26].
3. Host cell modifications in MV persistence
Modifications in MV-infected cells. The growth of RNA viruses depends on the mRNA
translation machinery of the cells. Many viruses modify the host cell machinery to favor
translation of their own mRNA. During the acute phase of MV infection, the virus induces
suppression of protein synthesis (designated “shut-off”) in host cells and viral mRNAs are
preferentially translated [27]. The phosphorylation of eukaryotic initiation factor (eIF) 2α
and the binding of the N protein to eIF3-p40, which are cellular initiation factors required
for cap dependent tranlation, are involved in the induction of shut-off [27, 28]. The La pro‐
tein is involved in the preferential translation of viral mRNAs [29]. All these modification
are found in the acute MV infection (Figure 1A). A persistent MV infection becomes clinical‐
ly apparent many years after the acute infection. There are no apparent symptoms in the
time between acute infection, and the onset of SSPE clinical symptoms; this would indicate
that replication of the persistently infecting MV is in equilibrium with replication of the host
cells. Some as yet unidentified modifications might be involved in disease progression dur‐
ing MV persistence (Figure 1B). These need to be investigated to understand the mecha‐
nisms of persistence and pathogenicity.
Modulation of  gene expression patterns  in  MV-infected cells.  Several  studies  examin‐
ing  gene  expression  in  MV-infected  cells  have  been  reported  [30-32].  MV  infection  of
dendritic cells up-regulates a broad array of interferon (IFN)-αs,  but fails  to up-regulate
double-stranded RNA-dependent protein kinases [31]. MV infection of human peripheral
blood mononuclear  cells  (PBMCs)  modulates  the  activity  of  NF-κB transcription  factors
[30].  MV infection also induces expression of  molecules  involved in defense against  en‐
Pathogenesis of Encephalitis Caused by Persistent Measles Virus Infection
http://dx.doi.org/10.5772/54434
253
doplasmic reticulum (ER) stress and apoptosis in PBMCs and human lung epithelial cells
[30,  32].  All  these  molecules  affected  in  MV-infected  cells  might  be  involved  in  SSPE
pathogenesis. As an example, long-term administration of IFNs is one type of SSPE ther‐
apy [33]. NF-κB may be a determinant of multiple sclerosis (MS) susceptibility, a chronic
demyelinating disease of the CNS in humans [34]. As glial cells appear to be vulnerable
to ER stress, altered expression of the molecules involved in ER stress can perturb myeli‐
nation  by  oligodendrocytes  [35].  Apoptotic  processes  have  also  been  suggested  to  con‐
tribute  to  MS,  where  local  tissue  damage  involves  apoptosis  of  oligodendrocytes  and
neurons [36].
Lipid metabolism in cells persistently infected with MV. Most studies examining gene ex‐
pression in MV-infected cells have been performed in non-neuronal cells. Because modula‐
tion in gene expression is cell-type dependent [37], studies using neuronal cells are more
informative. The molecules affected during persistent infection might be different from
those in the acute infection. Two studies using neuronal cells persistently infected with MV
revealed alterations in lipid metabolism, such as decreased cholesterol synthesis and im‐
paired β-oxidation, that were associated with MV persistence [38, 39]. Myelination is a com‐
plex process that requires a precise stoichiometry for gene dosage, along with protein and
lipid synthesis. An alteration in lipid metabolism during persistent MV infection would af‐
fect the maintenance of myelin in the CNS.
4. Reactivation mechanisms of persistent MV
It is known that persistent MV infection is asymptomatic but can eventually result in SSPE
[2]. The latent MV should be reactivated at the onset of disease, resulting in clinical signs of
SSPE (Figure 1C). However, the molecular mechanisms of MV persistence and reactivation
are yet to be elucidated.
Heat  shock  protein  72  (hsp72).  One  potential  molecule  involved  in  MV reactivation  is
hsp72. Hsp72 binds to two conserved motifs in the variable tail of the N protein, known
as box 2 (amino acids 489–506) and box 3 (amino acids 517–525) [40].  The tail  of  the N
protein is within the same area where the XD domain of the P protein (amino acids 459–
507) binds to the N protein [41].  In vivo  models using mice expressing hsp72, or hyper-
thermal preconditioned mice,  have revealed that hsp72 levels can serve as a host  deter‐
minant  of  viral  neurovirulence  in  mice.  This  indicates  the  direct  influence  of  hsp72  on
viral gene expression [42, 43]. Hsp72 induction by some type of reactivation event might
enhance  the  replication  of  persistent  MV  in  the  CNS,  resulting  in  the  onset  of  clinical
symptoms. Accumulation of the H protein inside the cell during persistent MV infection
might  be such a  reactivation event,  as  antibodies  against  the MV can decrease cell  sur‐
face expression of viral glycoproteins, which has been suggested to contribute to the es‐
tablishment of MV persistence [44, 45].  Indeed, overexpression of the H protein leads to
induction of hsp72 (Figure 2).
Encephalitis254
Figure 1. A model for the pathogenesis of persistent MV infection. (A) Acute infection. MV enters the CNS and infects
neurons and oligodendrocytes. (B) Persistent infection. MV establishes a persistent infection in the CNS. MV replica‐
tion is attuned to the host cells, with minor or reversible modifications of the cells. Minor or reversible modifications,
such as alterations in lipid metabolism, in MV-infected cells might be involved in a progressive infection. (C) Reactiva‐
tion. Some reactivation events stimulate the latent MV, leading to rapid replication in the CNS. (D) Demyelination. Re‐
activated MV destroys host cells, including oligodendrocytes, and drives damaging inflammatory responses, resulting
in demyelination. Damaging resulting from MV infection can lead to a spreading of epitopes that generate autoim‐
mune responses. The oligoclonal IgG found in the SSPE brain and the CSF, which is directed against MV, possibly cross-
reacts with myelin proteins. Activated autoreactive T cells, or T cells activated by viral antigens can cross the blood-
brain barrier and enter the brain parenchyma. These infiltrating inflammatory cells induce extensive lesions in the CNS.
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Figure 2. Hsp72 induction by the H protein. 293T cells were mock-transfected, or transfected with the H protein. At 24
h post-transfection, cells were harvested, and quantitative analysis of hsp72 was performed using quantitative real-
time RT-PCR. Values are expressed as mean plus S.E. and compared with those from mock-transfected cells. * p < 0.05.
Peroxiredoxin 1 (Prdx1). Prdx1, another potential molecule involved in SSPE, has recently
been identified as a critical component during MV replication and transcription [46]. It was
shown to bind to the same area of the N protein as the P protein (box 2), and competes with
binding of the P protein. A reduction in Prdx1 expression appears to result in a steeper MV
transcription gradient, as it has less of an effect on the N protein expression compared with
the L protein expression. The binding affinity of Prdx1 to the N protein is approximately 40-
fold lower than that for the P protein. This would suggest that Prdx1 may only play a role in
MV RNA synthesis during the early stages of infection, when the amount of cellular Prdx1
is much greater than that of the viral P protein [46]. Likewise, Prdx1 might play a role in the
reactivation of latent MVs that are attuned to host cells. Recent studies have implicated Prdx
as a target of age-related modifications [47]. Age-related modifications, such as hyperoxidi‐
zation, likely affect Prdx1 thereby influencing MV transcription, and may explain why it
takes several years after an acute MV infection for the first symptoms of SSPE to appear.
Post-translational modifications. Generally, infectious virus cannot be recovered from the
CNS at autopsy, or from a biopsy of SSPE cases. In SSPE, MV-specific inclusions are present
in the cytoplasm and nuclei of infected cells, and the incidence of certain types of inclusion
bodies decline with prolonged duration of the disease [12, 13]. The N protein is most abun‐
dantly expressed in infected cells, and a major component of MV-specific inclusions. The N
protein has been shown to be modified post-translationally by phosphorylation [48, 49]. The
phosphorylation at serine residues 479 and 510 in the tail of the N protein has been shown to
play an important role in viral replication and transcription [48]. Some reactivation events
might stimulate host cell kinases responsible for these phosphorylations. Other post-transla‐
tional modifications could possibly be involved in the reactivation of latent MV.
5. Pathogenesis of persistent MV infection
MV infection induces clinically significant immunosuppression, which can continue for
many weeks after an apparent recovery from measles [50, 51]. Long-lived cytokine imbalan‐
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ces and direct effects on the proliferation of lymphocytes are reportedly implicated with the
immunosuppression. In contrast, a persistent brain infection leads to a hyperimmune anti‐
body response, a pathogenic feature of SSPE [10, 11]. For example, there are extremely high
titers of neutralizing antibodies in the serum and CSF against viral structural proteins. The
immune system would appear to be involved in SSPE pathogenesis (Figure 1D).
Direct cytopathic effects. Persistent MV infection might destroy infected cells, including oli‐
godendrocytes, and damage inflammatory responses, thereby resulting in demyelination.
Consistent with this idea, there is a strong correlation among the extent of viral fusion activi‐
ty, cytopathic effects of MV, and severity of neurovirulence in a hamster model [23]. More
commonly, T and B cells may directly attack viral antigens expressed on persistently infect‐
ed glial cells and destroy these cells. Damage resulting from MV infection can lead to a
spreading of epitopes that may result in the generation of autoimmune responses [52]. In
SSPE patients, brain-antigen-reactive T cells are found in the periphery [53].
Autoantigen. Autoimmune responses to myelin proteins are considered to be possible caus‐
es of some demyelinating diseases including SSPE. The level of antibodies against CD9, a
glycoprotein that is abundant at the surface of myelin, is elevated and reaches a peak that
coincides with the appearance of brain atrophy in SSPE patients [54]. It has also been sug‐
gested that autoimmunity could arise as a result of cross-reactivity between viral and myelin
antigens [55, 56]. Myelin basic protein (MBP)-homologous sequences in the N and C pro‐
teins may account not only for encephalomyelitis in humans, but also for cross-reactions as
detected by delayed skin tests with MBP in measles-sensitized guinea pigs [57].
Superantigen.  Another  mechanism  has  been  proposed  that  implicates  superantigens  in
the  etiology  of  autoimmune  demyelinating  diseases  [58].  Superantigens  activate  T  cells
through the  variable  domain of  the  T  cell  receptor  β  chain.  This  distinctive  mode of  T
cell activation, together with the ability of superantigens to bind to a wide variety of ma‐
jor histocompatibility complex molecules outside the antigen groove, leads to one super‐
antigen activating a whole class of T cells irrespective of antigen specificity. Activated T
cells can cross the blood-brain barrier and enter the brain parenchyma. A few cells hom‐
ing to the brain have been shown to be enough to induce extensive lesions in the CNS
[58].  Once  activated,  autoreactive  T  cells  enter  the  brain  and  initiate  inflammatory  le‐
sions. The permeability of the blood-brain barrier increases, leading to an influx of solu‐
ble  factors,  such  as  tumor  necrosis  factor,  into  the  CNS.  All  these  events  will  result  in
extensive CNS lesions. Exogenous superantigens can be produced by bacteria, mycoplas‐
ma or viruses [59], and therefore the existence of superantigens during persistent MV in‐
fection should be investigated in future studies.
6. Conclusion
Many previous studies have demonstrated that changes in host cell homeostasis contrib‐
ute  to  the  pathogenesis  of  persistent  MV  infections.  Rapid  replication  of  MV  that  has
been quiescent for years is triggered by some reactivation event(s) and results in hyper-
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reactive immune responses.  Demyelination in persistent  MV infections is  due to a com‐
plex  combination  of  viral  cytopathic  effects  on  neuronal  cells  and  immune-mediated
mechanisms.  Although  the  pathogenesis  of  persistent  MV infection  remains  to  be  fully
elucidated, some of the key advances outlined in this review will provide novel insights
into  the  understanding  of  human  demyelinating  encephalitis,  and  other  encephalitis
types induced by viruses.
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